Equities

iSpecimen Inc

ISPC:NAQ

iSpecimen Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.2842
  • Today's Change-0.001 / -0.28%
  • Shares traded847.68k
  • 1 Year change-80.93%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.

  • Revenue in USD (TTM)9.27m
  • Net income in USD-11.57m
  • Incorporated2009
  • Employees53.00
  • Location
    iSpecimen Inc450 Bedford St Ste 1010LEXINGTON 02420-1535United StatesUSA
  • Phone+1 (781) 301-6700
  • Fax+1 (302) 655-5049
  • Websitehttp://www.ispecimen.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Avenir Wellness Solutions Inc3.55m-4.53m3.12m11.00------0.879-0.0615-0.06150.0481-0.14291.014.5513.29322,636.40-129.24-67.44---160.7169.8265.02-127.64-485.880.0799-426.64-----11.2152.8781.42---17.08--
Ubiquitech Software Corp-100.00bn-100.00bn3.18m2.00---------------0.0018------------------------0.2022--1.36--8,230.16---14.20------
Signing Day Sports Inc488.19k-7.11m3.23m14.00--13.41--6.61-0.6097-0.60970.04450.0150.2036--8.3434,870.71-296.53------80.94---1,456.56-----8.710.897--292.62--17.92------
Tianrong Internet Products and Srvcs Inc0.00-263.91k3.29m0.00---------0.0031-0.00310.00-0.00870.00-------334.06-----------------32.38---------120.66------
Infrax Systems Inc0.00-39.27k3.32m7.00---------0.00004-0.000040.00-0.000080.000.00-----5.17-44.99-14.42-135.59--80.37---1,435.400.0001-6.701.26-------108.72------
Totaligent Inc118.86k-6.30m3.46m----1.96--29.09-0.1676-0.16760.00140.01020.0989--0.969---524.43-2.51-814.08-7.6711.69---5,304.11-18.523.50-77.440.0608--------------
Healthcare Triangle Inc27.47m-10.92m3.65m23.00------0.1329-2.56-2.566.41-0.10812.14--7.22832,545.40-84.90---176.08--22.56---39.76-----9.331.24---27.64---28.40------
iSpecimen Inc9.27m-11.57m3.72m53.00--0.395--0.4010-1.27-1.271.020.71950.538--2.65174,867.40-67.16-49.18-92.94-145.1649.5853.26-124.84-90.30----0.00---4.5617.70-8.33--35.84--
Jet.AI Inc14.19m-13.20m3.83m9.00------0.270-1.53-1.531.58-0.22052.74----1,576,406.00-253.54---1,453.62---1.61---92.52-----70.74-----44.13---63.64------
Versus Systems Inc139.72k-10.69m3.86m14.00--0.3594--27.62-9.54-9.540.11754.280.0178--12.92---136.34-166.70-80.24-113.041.75---7,648.83-1,608.99---95.010.00---75.54193.2753.22---57.63--
Vocodia Holdings Corp13.19k-12.73m3.89m5.00--1.38--295.14-1.91-1.910.00180.0498-----------------359.14---96,524.64-----2.330.0819---61.09--58.03------
Next Technology Holding Inc2.63m20.92m4.02m8.00--0.05840.1921.53-22.23-38.742.0326.210.0452--0.6788329,163.8035.90--38.63--54.50--794.54------0.00------53.29------
Auddia Inc0.00-8.86m4.05m13.00--1.63-----11.18-11.180.000.8880.00----0.00-163.26-167.44-430.44-----287.81---6,751.12---6.530.6082-------27.69--5.10--
Asset Entities Inc340.75k-5.25m4.48m11.00--6.95--13.14-1.87-1.870.12170.21020.0836----30,977.27-128.65---136.54-------1,539.80------0.1309---19.26---664.22------
Data as of Jul 26 2024. Currency figures normalised to iSpecimen Inc's reporting currency: US Dollar USD

Institutional shareholders

2.29%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202476.56k0.59%
BlackRock Fund Advisorsas of 31 Mar 202456.54k0.43%
Millennium Management LLCas of 31 Mar 202444.06k0.34%
Geode Capital Management LLCas of 31 Mar 202438.50k0.29%
Grimes & Co., Inc.as of 30 Jun 202430.82k0.24%
Schonfeld Strategic Advisors LLCas of 31 Mar 202415.20k0.12%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 202413.81k0.11%
Main Street Financial Solutions LLCas of 31 Mar 202410.50k0.08%
Renaissance Technologies LLCas of 31 Mar 202410.00k0.08%
Tower Research Capital LLCas of 31 Mar 20243.19k0.02%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.